GORMAN KEVIN CHARLES (Chief Executive Officer) sold 32.4% of their position (245.09K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $37.82M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2026ACC: 0001201096-26-000010
DirectorOfficer· Chief Executive Officer
Since Feb 2019
-245.09K
Net shares
Net seller
$37.82M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
205.09K acquired · 450.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+205.09K
Price / share
$43.24
Trade value
$8.87M
% of position
37.2%
5/19/2026
551.29K→756.38K
Common Stock
Direct
Shares
−245.09K
Price / share
$154.33
Trade value
$37.82M
% of position
32.4%
5/19/2026
756.38K→511.29K
Total
Net shares
−40K
Net value
-$28.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2026 | M · Option Exercise | +205.09K | $43.24 | $8.87M | 37.2% | 551.29K | 756.38K |
| Common Stock Direct | 5/19/2026 | S · Sale | −245.09K | $154.33 | $37.82M | 32.4% | 756.38K | 511.29K |
| Total | −40K | -$28.96M | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
205.09K shares
Shares
−205.09K
Strike price
43.24
Held after
0.00
Exercisable
—
5/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock205.09K shares | 5/19/2026 | M · Option Exercise | −205.09K | 43.24 | — | 0.00 |